India markets closed

  • BSE SENSEX

    49,849.84
    +749.85 (+1.53%)
     

  • Nifty 50

    14,761.55
    +232.40 (+1.60%)
     

  • Dow

    30,932.37
    -469.63 (-1.50%)
     

  • Nasdaq

    13,192.35
    +72.95 (+0.56%)
     

  • BTC-INR

    3,544,169.00
    +197,655.50 (+5.91%)
     

  • CMC Crypto 200

    968.39
    +35.25 (+3.78%)
     

  • Hang Seng

    29,452.57
    +472.36 (+1.63%)
     

  • Nikkei

    29,663.50
    +697.49 (+2.41%)
     

  • EUR/INR

    88.6771
    -0.9937 (-1.11%)
     

  • GBP/INR

    102.3865
    -0.8143 (-0.79%)
     

  • AED/INR

    19.9840
    -0.0960 (-0.48%)
     

  • INR/JPY

    1.4480
    +0.0090 (+0.63%)
     

  • SGD/INR

    55.2790
    -0.3150 (-0.57%)
     

Top 12 finance news of the day, July 13, 2020

·4-min read

Top financial highlights of the day:

India's retail inflation for June picks up to 6.09% after increase in prices of food items

India's annual retail inflation rose to 6.09% in June compared with 5.84% in March, pushed by a bigger increase in prices of some food items, government data showed on Monday. Read more

Wipro has no plan to lay off employees due to pandemic: Rishad Premji

Bengaluru, Jul 13 (PTI) Wipro Chairman Rishad Premji on Monday said the company has not laid off any employee due to the COVID-19 impact and has no plans to do so for now. Read more

Gold Price hovers near record highs; silver above Rs. 52000/Gm

Gold price in the domestic market continued their upward move and traded higher by 0.38% at Rs. 49048 per 10 gm. In the previous day's trade, gold hit a high of Rs. 49,230 per 10 gm. Read more

RIL hits record high; becomes Rs. 12-trillion M-cap company

After whopping gains of over 100% since March lows, RIL stock in Monday's (July 13, 2020) opening trade jumped to a new high of Rs. 1917 per share. The stock ever since its rights issue and back to back investment into its digital arm Jio Platforms has been on a high.And in the process the company has now become the first Indian company to hit market cap of Rs. 12 trillion. Read more

Top 4 ways to handle corporate abuse

As we continue to grow up, we gain a lot of responsibilities, and as adults, we need to fulfill our basic needs too. To fulfill those needs, all we need to do is to find a perfect job and have money.
But as we enter the corporate world, the main thing that terrifies everyone about it is corporate abuse. Read more

Fully autonomous self-driving cars may take years to come, experts say difficulties ahead

The road to fully self-driving vehicles remains riddled with obstacles, with years of refinements likely needed, despite Tesla founder Elon Musk’s claim to be able to produce one this year. Musk’s suggestion that Tesla is nearing "Level 5" autonomy appeared to stun the sector, which has repeatedly pushed back forecasts for vehicles able to operate without human help. Read more

Google announces $10 billion for digitalising India

On Monday, Google and Alphabet CEO Sundar Pichai announced $10 billion investment at the Google for India event. "Today at #GoogleForIndia we announced a new $10B digitization fund to help accelerate India's digital economy. We're proud to support PM @narendramodi's vision for Digital India - many thanks to Minister @rsprasad & Minister @DrRPNishank for joining us," Pichai said in a tweet. Read more

LinkedIn faces lawsuit over claims it 'secretly' read iPhone clipboard data

The clipboard detection in iOS 14 isn’t just prompting developers to rethink app privacy — it’s also putting these companies in legal trouble. Reuters reports that iPhone user Adam Bauer has sued LinkedIn over claims the job-focused social network “secretly” read iOS clipboard data often, including the Universal Clipboard that shares copied content with nearby devices. The Microsoft-owned firm was spying on users, according to the lawsuit, and allegedly violated California law in the process. Read more

VR time machine helps an inventor relive his past

Life is made of fleeting moments that you may easily forget, but one inventor might have found a way to remember it... much of it, anyway. As PetaPixel reports, Lucas Rizzotto recently developed a virtual reality “time machine” that lets him revisit any moment recorded using camera-equipped Snap Spectacles. He just needs to dial in a Back to the Future-style “destination time” to see what he was doing at a given moment from his perspective, complete with flashy effects. Read more

IT industry to see more lay offs as COVID-19 pushes challenges for the sector

Amid the ongoing pandemic crisis, when there is dearth of projects, IT industry across the globe is on a downsizing spree. This is there on account of excessive workforce. Read more

Mark Zuckerberg, Jeff Bezos, Bill Gates really 'self-made'? This viral Twitter thread debunks myths

In 2018, Forbes listed Kylie Jenner, of Kylie cosmetics and reality TV fame, as one of the richest 'self-made' people in America.However, the (then) 21-year-old's nomination stirred up a controversy about what the tag 'self-made' really meant. Many felt that considering she is part of the Kardashian clan and has appeared on her step sisters' unnecessarily famous TV show from age 13, the cosmetics moghul is barely on her own and that Kim Kardashian's star-power was enough to propel young Kylie forward, not to mention her family wealth. Read more

MG Hector Plus six-seater SUV to launch today - Watch it live here

MG is all set to launch the six-seater version of the Hector - the Hector Plus in India today. The car will be placed above the Hector in terms of pricing and will have an additional row of seats at the back.

Latest stories

  • OPEC oil output falls in February on Saudi additional cut - survey

    OPEC oil output fell in February as a voluntary cut by Saudi Arabia added to agreed reductions under a pact with allies, a Reuters survey found, ending a run of seven consecutive monthly increases. OPEC and allies, known as OPEC+, decided to keep supply mostly steady for February while Saudi Arabia made an extra cut out of concern about a slow recovery in demand. With oil rising to a 13-month high last week, OPEC+ is set to discuss pumping more at a meeting on Thursday.

  • After Australia row, Facebook signs up partners for German news product

    Described as a "dedicated venue for journalistic content", Facebook News will feature reporting from heavyweight news weeklies Die Zeit and Der Spiegel, and newspapers including the Frankfurter Allgemeine Zeitung, Handelsblatt and Tagesspiegel. "Part of our user base wants to read more news," Jesper Doub, Facebook's director of news partnerships in Europe, told reporters. Facebook News has launched in the United States and Britain, and will follow soon in France, added Doub.

  • 'Religiosity in Pakistan leading to rise in terrorism in Pakistan'

    Islamabad [Pakistan], March 1 (ANI): With terrorist attacks in Pakistan which is witnessing a growing religiosity that has brought greater intolerance among its people, experts have expressed concern about the possibility of the country being engulfed by religious extremism.

  • China says Taiwan pineapple ban not about politics as war of words escalates

    China on Monday denied accusations by Taiwan that a ban on pineapples from the island was about politics, saying it was purely a matter of biosecurity, in an escalating war of words that has added to existing tensions. China announced the ban last week, citing "harmful creatures" it said could come with the fruit, threatening China's own agriculture. Taiwan, which China claims as its own territory, says there is nothing wrong with its pineapples and that Beijing is using the fruit as another way to coerce the island.

  • West Indies To Play A Four-Day Practice Game Ahead Of The Test Series Against Sri Lanka

    Ahead of the two-Test series against Sri Lanka in Antigua, the West Indies will engage in a practice match. The Coolidge Cricket Ground will stage the warm-up game for which the Cricket West Indies has announced a 26-member squad, combining two teams. Lead selector Roger Harper revealed the concept and outlined the details. Opening batsman Kraigg Brathwaite and middle-order batsman Roston Chase will lead the squad A and B, respectively. West Indies’ last Test series – an away series against Bangladesh proved to be a stellar one as they beat the Tigers by 2-0 with a depleted squad. On this The post West Indies To Play A Four-Day Practice Game Ahead Of The Test Series Against Sri Lanka appeared first on CricketAddictor.

  • Cummins Names Lamb-Hale Vice President and General Counsel

    Cummins Inc. (NYSE: CMI) announced today Nicole Y. Lamb-Hale is succeeding Sharon Barner as Vice President and General Counsel, effective in May. The company announced on February 2 that Barner is being promoted to Vice President and Chief Administrative Officer.

  • UNITYsat trio, SindhuNetra, SD Sat: Students built five of the payloads in ISRO's PSLV-C51 mission

    25,000 names are being flown in SD Sat, in an effort to spread public awareness in India about space and missions to explore it.

  • Field Service Management (FSM) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

    The Global Field Service Management Market (henceforth referred to as the market studied) was valued at USD 2. 85 billion in 2019, and it is expected to reach USD 7. 10 billion by 2026, registering a CAGR of 15.New York, March 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Field Service Management (FSM) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" - https://www.reportlinker.com/p06028486/?utm_source=GNW 4%, during the period, 2021-2026.Field service management firms are experiencing immense pressure to effectively lead teams and ensure safety compliance with the outbreak of COVID-19, where the risks are running high. There is no space for miscommunication or distrust. According to Harvard Business Review, before the pandemic, the U.S. average for organizational trust was only 70%. Seeing as stressful situations exacerbate fear and distrust, it is even more critical at this point of time to focus on developing confidence within the organization.In the wake of COVID-19, the previously estimated growth of FSM across end-user segments are expected to rise as the pandemic restricts the industry professionals and stakeholders to manage their fieldwork remotely. The COVID-19 pandemic has resulted in limited workers at the floor to have social distancing measures, which will further boost the adoption.- Also, the field service management industry has been witnessing rapid growth over the last few years, buoyed by the increasing demand for time and cost-effective solutions. Several studies have revealed that there would be a shortage of field service workforce in mature markets such as the U.S. and Europe, due to the prevalent demographic conditions, which has, in turn, led to organizations placing a higher emphasis on back-end automation and use of advanced technologies to enable remote monitoring.- Various pricing strategies are being implemented by the vendors to survive in the competitive market environment. The software vendors are adopting customer-centric pricing strategies enabled by technological advancements. Several vendors in the FSM industry are focusing on providing value-based pricing models depending on the needs of the customers and value perception. The software solution pricing is based on the differentiating characteristics of the solution and the value-added features given to the customers.- The preference for software-as-a-service (SaaS) over the traditional on-premise software is set to increase considerably during the forecast period, aided by the growing demanding for better and faster service. With the growth of cloud computing in the field service management market, many enterprises are switching to cloud-based FSM solutions. These solutions ease the burden on the I.T. department and allow the external service providers to offer support and maintenance to their users.- The original equipment manufacturers are adopting the industrial Internet of things (IIoT) for new services, which require a modern FSM system to manage the field service delivery leading to an increased demand for FSM solutions. Additionally, machine learning provides new sources of competitive advantage. The successful execution of this requires modern FSM solutions. There has been an increasing adoption of field service management solutions, as it improves workforce productivity and streamlines the business process without increasing the size of the field-based workforce.Key Market TrendsInventory Management to Hold Significant Market Share- Inventory management is one of the most mismanaged components of the field services segment. Several factors, such as returns, component failure, and warranty issues, make it one of the most complex tasks in the field services industry. Hence, deploying inventory management solutions help the service providers to provide the right parts to customers accordingly, in a cost-effective manner.- Since most technicians carry and manage spare parts, the policies, like BYOD, allow the technicians to monitor and update their inventory from a mobile device to simplify management. For example, General Electric’s (GE) ServiceMax FSM software even allows the technicians to track and search spare parts in their fleet to facilitate exchanges between technicians if necessary. Such practices are witnessed in the consumer electronics service industries and several B2B operations.- In November 2019, Comarch Improved the Hospital Inventory Management by Cloud-based FSM Software for MedicAir in Italy. The company’s cloud-based Field Service Management (FSM) will ensure hospital inventory management in all the warehouses where the medical gases are stored. The staff from the hospital will be able to order equipment, which will be delivered from the warehouse to the specific unit. Additionally, the team will be able to monitor the cylinder’s location, gas level and use, and the expiry date for gas and cylinder.- Further, the increasing development of AI has led to AI Field Management, which is a cloud-based solution that helps both small and large enterprises to manage and collaborate with field employees. It also includes a customer website portal, inventory management, time tracking, payroll reports, and job management. The increasing availability of SaaS solutions and value-added features, such as system alerts and analytics services, provided by the inventory management solutions, is expected to increase the affordability and efficiency of the inventory management solutions. This factor is increasing the adoption among large and small organizations alike.Asia Pacific to Witness Significant Growth Rate- Asia-Pacific is expected to dominate the regional field service management market, and it’ s rapid rate of growth is attributed as the region is being home to a large number of SMEs, which are highly involved in the development and adoption of field services and their management solutions. China is one of the largest E-Commerce markets in the world. The expansion in the sector is a significant driver for the adoption of FMS solutions. And as more and more new retail is shifting from a novel concept to the mass market sector, the need for the management of filed service will also grow.- The field service management market has a vast scope in India, mainly due to large-scale industrialization. The country is expected to exhibit steady growth in the field service management market with enhanced geographic zones and a high client base. The growth in the number of technology users in the country further propels the growth of the field service management market. In December 2019, Field Service Management Summit was held in India which covered the topics such as technology, skills and change management strategies required to meet the increasing complexity of the field service touchpoint, future of IoT for field services management, addressing the challenges in third-party workforce management & third billing, increasing first-time fix rates to achieve higher customer satisfaction and profits, etc.- Japanese service companies have laid a roadmap to commence specific changes with the business transformation years behind the United States. In January 2020, Accenture in Japan plans to achieve digital transformation by following the example of a parts-maker in Europe that has so far been very effective in integrating cloud applications, SaaS platforms, connected devices, and artificial intelligence (AI). By pursuing digital transformation, the parts-maker was able to connect every aspect of its field services management, such as central operations, dispatch, repair, predictive maintenance, and other activities.- Field service management for manufacturing organizations is increasing in the region where Manufacturers in South East Asia are no exception, and also happen to be significant growth drivers for the region. It’s an exceptionally substantial sector right now for the region with China’s rising wages, tighter regulations, and trade wars leading some companies to consider moving their manufacturing to South East Asia. The companies are utilizing service management (FSM) solution that uses the predictive maintenance or IoT triggers to generate work activities and, in real-time, find the best-suited field technician to be on-site to perform the work activity.Competitive LandscapeThe market landscape of the Field Service Management (FSM) market remains quite fragmented. Various vendors of pre-packaged FSM software solutions exist, but no single FSM vendor has ever dominated the global market or any regional markets. There are several mergers, partnerships, and collaborations happening in the market among the players.- May 2020 - FieldAware and Localz, a provider of real-time customer communications and service tracking solutions, announced a partnership to bring day-of-service connections to field service organizations. FieldAware has partnered with Localz to expand its cloud-based field service management hub offerings to build better service experiences. Localz On My Way complements and extends the functionality of the FieldAware offering to include automated customer communications, real-time service tracking, and feedback capabilities to existing workflows.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p06028486/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Woking council accused of discouraging vulnerable voters

    Woking council accused of discouraging vulnerable votersConservative-run borough asking for photo ID to register for proxy or postal votes, though this is not required by law In England, Scotland and Wales, only a signature and date of birth is required to apply for a postal vote. Photograph: Lesley Martin/PA

  • Outlook on the Biosolids Global Market to 2027 - Featuring Alka-Tech, BCR Environmental and Englobe Among Others

    Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "Biosolids - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 7th edition of this report. The 131-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Biosolids Market to Reach US$188.1 Million by the Year 2027Amid the COVID-19 crisis, the global market for Biosolids estimated at US$133.5 Million in the year 2020, is projected to reach a revised size of US$188.1 Million by 2027, growing at a CAGR of 5% over the analysis period 2020-2027. Agricultural Land Applications, one of the segments analyzed in the report, is projected to grow at a 5.3% CAGR to reach US$115.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Agricultural Land Applications segment is readjusted to a revised 4.8% CAGR for the next 7-year period. This segment currently accounts for a 20.9% share of the global Biosolids market.The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 4.8% CAGR for the Period of 2020-2027The Biosolids market in the U.S. is estimated at US$39.4 Million in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$33.3 Million in the year 2027 trailing a CAGR of 4.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR while Rest of European market (as defined in the study) will reach US$33.3 Million by the year 2027.Energy-Related Applications Segment Corners a 18.9% Share in 2020In the global Energy-Related Applications segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$20.3 Million in the year 2020 will reach a projected size of US$27.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$21 Million by the year 2027. Competitors identified in this market include, among others: Alka-TechBCR EnvironmentalBiocore Environmental Ltd.BIODISK CorporationBurch Biowave-Burch Hydro Inc.Cambi Group ASCasella Waste Systems, Inc.EnglobeFergus Power Pump, Inc.GeoEnvironment TechnologiesLystek International, Inc.Managed Organic Recycling, Inc. (MOR)Merrell Bros., Inc.New England Fertilizer Co. (NEFCO)Noram Engineering and Constructors Ltd.Parker Ag Services, LLC.Parkson CorporationRecyc Systems, Inc.SylvisSynagroTerratec Environmental Ltd.Walker IndustriesWm. H. Reilly & Co. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Impact of Covid-19 and a Looming Global RecessionGlobal Competitor Market SharesBiosolids Competitor Market Share Scenario Worldwide (in %): 2018E 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISIV. COMPETITION Total Companies Profiled: 43 For more information about this report visit https://www.researchandmarkets.com/r/o9b0et CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Vertex Welcomes Sal Visca as Chief Technology Officer

    KING OF PRUSSIA, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, is pleased to welcome Sal Visca as chief technology officer (CTO) effective immediately. He is responsible for leading the company’s technology strategy, software engineering and innovation roadmap to accelerate growth. Visca brings 30 years of technology and executive management expertise transforming and operating large-scale cloud software businesses. He is an experienced board member and advisor to public and private corporations in the artificial intelligence (AI), cybersecurity and SaaS industries. Previously, he served as CTO at Elastic Path Software, where he drove their pioneering efforts in “headless commerce.” In addition, he led architecture, engineering and cloud operations to scale the company’s B2C and B2B omnichannel commerce platform to support over $60B in online transaction volume with customers including Carnival Cruise Lines, Comcast, Intuit and T-Mobile. “Sal is a visionary with deep, proven experience pioneering next generation commerce, business intelligence and enterprise management applications,” said Vertex Chief Executive Officer David DeStefano. “We set out to find an exceptional, purpose-driven leader – someone with that rare mix of interpersonal skills, technical savvy and an innovative spirit to run a leading-edge technology organization – we are fortunate to welcome Sal to Vertex.” Visca previously held CTO positions at Business Objects and Infowave Software. He was also senior vice president and CTO of SAP’s Application and BI Platform Group. At SAP he was responsible for strategy, central architecture guidance and governance in driving new products and long-term innovation, including helping to develop HANA, a breakthrough in-memory analytics engine, now one of the company’s most widely used and fastest growing products. After obtaining a bachelor’s degree with honors in computer science from Western University, Visca spent his early career at IBM, spanning 12 years as a software engineer, architect and then in executive roles developing the company’s e-commerce and middleware products. “This is an incredible opportunity to help shape the future of global commerce with a leading, respected industry brand that stands for trust and innovation. I am excited to lead the next generation of tax technology, enabling our customers to accelerate business growth globally,” said Visca. About Vertex Vertex, Inc. is a leading global provider of indirect tax software and solutions. The company’s mission is to deliver the most trusted tax technology enabling global businesses to transact, comply and grow with confidence. Vertex provides cloud-based and on-premise solutions that can be tailored to specific industries for major lines of indirect tax, including sales and consumer use, value added and payroll. Headquartered in North America, and with offices in South America and Europe, Vertex employs over 1,200 professionals and serves companies across the globe. For more information, visit www.vertexinc.com or follow on Twitter and LinkedIn. Source: Vertex, Inc. Company contact: Tricia Schafer-PetreczVertex, Inc.tricia.schafer-petrecz@vertexinc.com484.595.6142 Investor Relations contact: Ankit Hira or Ed YuenSolebury Trout for Vertex, Inc.ir@vertexinc.com610.312.2890

  • 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round

    Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced therapies sector, announced it has become an investor in CARISMA Therapeutics, a biopharmaceutical company focused on discovering and developing innovative immunotherapies. 4BIO participated in the second closing of CARISMA’s $59 million Series B round, alongside founding investors IP Group, Inc. and Penn Medicine, joining the initial Series B investor syndicate of SymBiosis II, Solasta Ventures, Livzon Pharmaceuticals Group, AbbVie Ventures, HealthCap, Wellington Partners, TPG Biotech, Agent Capital and MRL Venture Fund. The financing round will be used to advance CARISMA’s current pipeline and discovery programs, including the phase I clinical trial of its lead candidate, CT-0508, an anti-human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M), which recently initiated trial enrollment and patient screening for the first-of-its-kind, first-in-human study of CT-0508. The funding will also allow CARISMA to further develop its proprietary engineered-macrophage platform, continue pipeline expansion in cancer indications and enable the platform’s application to disease areas outside of cancer. Dr. Dima Kuzmin, Managing Partner at 4BIO Capital, said: “We are delighted to be investing in such a unique and innovative company like CARISMA, as the team there strives to develop transformative therapies that will change the way we treat solid tumours. As CARISMA progresses the development of its lead candidate into phase I clinical trials, we are pleased to be supporting the Company’s ambitions alongside such a high quality investor syndicate.” Steven Kelly, President and Chief Executive Officer at CARISMA Therapeutics, said: “We are pleased to receive additional support from one of our founding investors, IP Group, Inc., as well as Penn Medicine, and new participant, 4BIO Capital, a fund committed to solely investing in advanced therapies. With our lead candidate, CT-0508, now officially in Phase I clinical trials, this additional funding puts CARISMA in an even stronger position in the field of immunotherapy as we advance our mission of evaluating the potential of engineered macrophages.” -End- Contacts 4BIO Capital+44 (0) 203 427 5500info@4biocapital.com AccessAlpha Worldwide LLC+1 (312) 585 60004BIO@AccessAlpha.com Consilium Strategic CommunicationsAmber Fennell, Olivia Manser, Lizzie Seeley, Maya Bennison+44 (0)20 3709 57004biocapital@consilium-comms.com About 4BIO Capital 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, please visit www.4biocapital.com About CARISMA Therapeutics Inc. CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com

  • Pakistani court grants bail to Christian in blasphemy case

    A Pakistani court on Monday granted bail to a Christian man convicted in 2018 while still a teenager of insulting Islam by posting a picture of Islam's holiest site on social media, a defense lawyer said. The court order in the eastern city of Lahore came more than four years after Nabeel Masih was arrested. According to his lawyer, Naseeb Anjum, Masih was granted bail by the Lahore High Court.

  • Misonix to Participate in Upcoming March Investor Conferences

    FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Cowen 41st Annual Healthcare Conference and the Oppenheimer 31st Annual Healthcare Conference on March 4th and March 16th, respectively. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be available to host one-on-one meetings with investors who are registered to attend the conferences. Cowen 41st Annual Healthcare ConferenceDate: Thursday, March 4, 2021Presentation: 9:50 a.m. ET Oppenheimer 31st Annual Healthcare ConferenceDate: Tuesday, March 16, 2021Presentation: 4:30 p.m. ET For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations firm, JCIR, at mson@jcir.com. About Misonix, Inc. Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com. Contact: Joe DwyerNorberto Aja, Jennifer NeumanChief Financial OfficerJCIRMisonix, Inc.212-835-8500 or mson@jcir.com631-927-9113

  • Type 1 Diabetes Market Size is Projected to Reach USD 2,800 Million by 2026, Globally: Facts & Factors

    According to the [175+ Pages] research study; the global Type 1 Diabetes Market in 2019 was approximately USD 2,000 Million. The market is expected to grow at a CAGR of 5% and is anticipated to reach around USD 2,800 Million by 2026. Top market players are B.BraunMelsungen AG, AstraZeneca PLC., Bayer Pharmaceuticals, DiaVacs Inc., Eli Lilly and Company and others.New York, NY, March 01, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026”. “According to the research study, the global Type 1 Diabetes Market was estimated at USD 2,000 Million in 2019 and is expected to reach USD 2,800 Million by 2026. The global Type 1 Diabetes Market is expected to grow at a compound annual growth rate (CAGR) of 5% from 2019 to 2026”. Type 1 diabetes is a type of diabetes where an autoimmune response towards insulin-making beta cells of the pancreas leads to the early destruction of the pancreas. Type 1 diabetes mellitus is idiopathic but has a strong association with genes such as HLA-DR4 and HLA-DR3. Type 1 diabetes symptoms are increase thrust, extreme weight loss stomach upset, increase frequency of urination, fatigue, delayed healing, etc. One of the key remedies against type 1 diabetes is insulin therapy. Parents and the child should have proper knowledge of the condition. The primary goal in the case of type 1 diabetes is to keep the insulin level as close to normal. The treatment prescribed to the patient involves monitoring the blood sugar level within limit via diet, exercise, and insulin therapy. If left untreated, the type 1 diabetic patient experiences loss of consciousness. Uncontrolled diet and insulin may cause high blood sugar (hyperglycemia), increased ketones in urine, hypoglycemia, etc. Request Your Free Sample Report of Type 1 Diabetes Market @ https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256 (The free sample of this report is readily available on request). Our Free Sample Report Includes: 2020 Updated Report Introduction, Overview, and In-depth industry analysisCOVID-19 Pandemic Outbreak Impact Analysis Included190+ Pages Research Report (Inclusion of Updated Research)Provide Chapter-wise guidance on Request2020 Updated Regional Analysis with Graphical Representation of Size, Share & TrendsIncludes Updated List of table & figuresUpdated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue AnalysisFacts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Questions Answered in this Report 1) What was the impact of COVID-19 on the Type 1 Diabetes Market? 2) What is the market size, share of the Type 1 Diabetes Market? 3) Who are the top market players in the Type 1 Diabetes Market? 4) What will be the future market of Type 1 Diabetes Market? Key Offerings: Market Size & Forecast by Revenue | 2020−2026Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunitiesMarket Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geographyCompetitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/type-1-diabetes-market-by-insulin-analog-rapid-1256 (You may enquire a report quote OR available discount offers to our sales team before purchase.) Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever. We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients. Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256 In the last few years, there has been a steady rise in type one diabetes in children. Changing lifestyles in urban and rural parts of the world have led to the high exposure of pollution and unhealthy diet patterns among children, which has led to an increase in the number of children affected with type 1 diabetes. Type 1 diabetic patients have to rely solely on external insulin supply. These patients have to carry insulin pens for medication. Owing to such primary dependency of patients insulin has driven the global injectable insulin market. With the advancements of biomedical technology, the emergence of genetic consulting is anticipated to create new types of treatments for type 1 diabetes. Also, the Food and Drug Administration approved the first-ever artificial pancreas for type 1 diabetic patients aging 14 and old. Such technological advancements are likely to create new avenues for the global type 1 diabetic market. However, lack of awareness among patients regarding types of treatment available has hampered the market for injectable insulin for type 1 diabetes. Top Market Players: Eli Lilly and CompanyBayer PharmaceuticalsSanofiNovo NordiskAstraZeneca PLC.XOMA Corp.DiaVacs Inc.B.BraunMelsungen AGBiodel Inc.Macrogenics Inc.Takeda Pharmaceutical To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/type-1-diabetes-market-by-insulin-analog-rapid-1256 Based on insulin analog, the rapid-acting insulin analogs segment dominated the global type 1 diabetes market, accounting for a market share of 40% in 2019. A rapid-acting insulin is taken 15 minutes before a meal. Rapid-acting insulin has an onset and peak of nearly 15 minutes and 30 to 90 minutes respectively. Rapid-acting insulin offers a key advantage as it controls postprandial glucose. The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the type 1 diabetes sector. Key strategic developments in the type 1 diabetes market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the type 1 diabetes market are appropriately highlighted in the report. The type 1 diabetes market research report delivers an acute valuation and taxonomy of the type 1 diabetes industry by practically splitting the market on the basis of different types, categories, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/type-1-diabetes-market-by-insulin-analog-rapid-1256 Diabetes is a defect in metabolism in the pancreas which results in hyperglycemia. Type 1 diabetes also known as insulin-dependent diabetes mellitus or juvenile diabetes is a condition where there is an immune response against insulin-producing beta cells of the pancreas. In type 1 diabetes, there has to be an external supply of insulin hence called insulin-dependent diabetes mellitus. The most severe form of diabetes leads to the early destruction of organs. A person can prevent type 2 diabetes by avoiding sugar enrich food products in the diet, however, such prevention is not possible when it comes to type 1 diabetes. The immune system strikes colonies of cells in the body that would normally generate insulin, called islets, blocking or slowing down insulin supply. In recent years, there has been a steady rise in the number of type 1 diabetic patients. Type 1 diabetes is treated with injectable insulin and this type of insulin can't be treated with oral supplements. Injectable insulin uses an insulin pen to inject insulin under the skin. Type 1 diabetic patients have to mainly rely on injectable insulin. Such dependency on patients has driven the global type 1 diabetes insulin market. Request Customized Copy of Report @ https://www.fnfresearch.com/customization/type-1-diabetes-market-by-insulin-analog-rapid-1256 (We customize your report according to your research need. Ask our sales team for report customization.) The type 1 diabetes market is segmented based on drug type and region. On the basis of insulin analogs, the market is classified into rapid-acting insulin analogs, long-acting insulin analogs, and premix insulin analogs. Based on geography, the North America segment dominated the global type 1 diabetes market in 2019. The North America region held a major share of nearly 35% in the global type 1 diabetes market in 2019. The growth in the region is attributable to rising consumer spending on healthcare and advancements in healthcare technology. Further, the increase in the number of type 1 diabetic patients has also contributed to driving the North America type 1 diabetes market. Browse the full “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” report at https://www.fnfresearch.com/type-1-diabetes-market-by-insulin-analog-rapid-1256 This report segments the type 1 diabetes market as follows: Global Type 1 Diabetes Market: By Insulin Analog Segmentation Analysis Rapid-Acting Insulin AnalogsLong-Acting Insulin AnalogsPremix Insulin Analogs Key Insights from Primary Research Our primary respondents predict that the global type 1 diabetes market is expected to grow at a CAGR of nearly 5% over the projected period.The rising number of type 1 diabetes patients around the world has driven the consumption of insulin, which has driven the type 1 diabetes market.Our primary respondents also estimate that the global type 1 diabetes market in 2026 is expected to reach a market value of nearly USD 2,800 million.Asia Pacific market is anticipated to grow at the fastest rate over the projected period owing to the increasing population and rising number of type 1 diabetic patients.Emerging technologies in healthcare have led to the development of artificial pancreas is likely to create favorable conditions for new types of diabetic treatments. Related Reports: Antibody Drug Conjugates Market: https://www.fnfresearch.com/antibody-drug-conjugates-market-by-drugs-adcetris-and Protein Ingredient Market: https://www.fnfresearch.com/protein-ingredient-market-by-product-type-plant-protein-1232 Orthopedic Trauma Devices Market: https://www.fnfresearch.com/global-orthopedic-trauma-devices-market-by-product-type-1220 Intravenous Iron Drugs Market: https://www.fnfresearch.com/intravenous-iron-drugs-market-by-product-iron-dextran-1201 Drug Delivery in Cancer Market: https://www.fnfresearch.com/drug-delivery-in-cancer-market-by-product-liposomes-1157 About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch Follow Us Twitter: https://twitter.com/fnfresearch Contact Us: Facts & Factors USA: +1-347-989-3985 Email: sales@fnfresearch.com Web: https://www.fnfresearch.com Blog: http://fnfnewsblog.com

  • Are your children taking part in the Oxford/AstraZeneca vaccine trial?

    Are your children taking part in the Oxford/AstraZeneca vaccine trial?We would like to hear from parents whose children are taking part in the vaccine trial and their experiences Researchers will use 300 volunteers to assess the immune response in children. Photograph: Ian Forsyth/Getty Images

  • Viewers praise relatable breastfeeding advert which aired during Golden Globes break

    The ad has been praised for offering a realistic and relatable view of breastfeeding and new motherhood.

  • Brazil variant: Government unable to say how many arrivals fail to fill in details, amid hunt for missing patient

    Downing Street says there are only ‘very few rare cases’ of non-compliance – but does not ‘have a percentage’

  • LPG price hiked again by Rs 25; ATF price up 6.5%

    <p>New Delhi, Mar 1 (PTI) Cooking gas LPG price was on Monday hiked by Rs 25 per cylinder across all categories, including subsidised fuel and those availed by Ujjwala scheme beneficiaries - the fourth increase in rates in a month's time.</p>

  • AIMIM Will Contest Tamil Nadu Polls: Party Chief Asaduddin Owaisi

    The Tamil Nadu Assembly polls are being held in a single phase on 6 April.